𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Experience with interferon alpha 2b combined with dacarbazine in the treatment of metastatic malignant melanoma

✍ Scribed by Carla I. Falkson

Book ID
112563872
Publisher
Springer US
Year
1995
Tongue
English
Weight
712 KB
Volume
12
Category
Article
ISSN
1357-0560

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Treatment of metastatic malignant melano
Treatment of metastatic malignant melanoma with recombinant interferon alfa-2b
✍ T. Dorval; T. Palangie; M. Jouve; E. Garcia-Giralt; E. Falcoff; D. Schwab; M. Le πŸ“‚ Article πŸ“… 1987 πŸ› Springer US 🌐 English βš– 151 KB

Twenty-six patients with histologically proven metastatic malignant melanoma were included in a phase II trial of interferon alfa-2b (Intron A; Schering-Plough). Patients were given 10 X 10(6) IU/m2 of interferon alfa-2b subcutaneously three times a week until major intolerance or progression of dis

Induction of tyrosinase-reactive T cells
Induction of tyrosinase-reactive T cells by treatment with dacarbazine, cisplatin, interferon-alpha Β± interleukin-2 in patients with metastatic melanoma
✍ Alexander Schmittel; Ulrich Keilholz; Regina Max; Eckhard Thiel; Carmen Scheiben πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 92 KB πŸ‘ 2 views

We have shown the presence of tyrosinase-reactive T cells in the peripheral blood of melanoma patients, who had been in remission after treatment with IL-2-containing regimens. In this consecutive study, we analyzed the T-cell response to various peptides derived from tyrosinase in serial blood samp